What is Stage 1 Intrauterine Growth Restriction (IUGR)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 25, 2025 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Stage 1 Intrauterine Growth Restriction (IUGR)

Stage 1 IUGR is characterized by abnormal umbilical artery Doppler with decreased diastolic flow, requiring increased frequency of testing and consideration for delivery after 37 weeks of gestation. 1

Definition and Classification of IUGR

IUGR is defined as sonographic estimated fetal weight below the 10th percentile for gestational age. It represents a condition where a fetus fails to reach its genetic growth potential, often due to placental insufficiency. 1

The staging of IUGR is based on progressive deterioration in fetal Doppler studies, which reflects worsening placental function:

  • Stage 1 IUGR: Abnormal umbilical artery Doppler with decreased diastolic flow
  • Stage 2 IUGR: Absent end-diastolic flow in the umbilical artery
  • Stage 3 IUGR: Reversed end-diastolic flow in the umbilical artery

Diagnostic Criteria for Stage 1 IUGR

  • Estimated fetal weight <10th percentile for gestational age
  • Abnormal umbilical artery Doppler showing decreased diastolic flow
  • Normal fetal heart rate patterns and biophysical profile
  • No evidence of absent or reversed end-diastolic flow

Clinical Significance of Stage 1 IUGR

Stage 1 IUGR represents early placental insufficiency and carries increased risks for:

  • Perinatal mortality and morbidity
  • Impaired neurodevelopmental outcomes
  • Long-term health consequences including hypertension and obesity in adulthood 1

Management of Stage 1 IUGR

Surveillance

  • Weekly umbilical artery Doppler assessment
  • Increased frequency of fetal testing (twice weekly non-stress tests with weekly amniotic fluid evaluation or weekly biophysical profile)
  • Serial ultrasounds to monitor growth progression

Timing of Delivery

  • Consider delivery at >37 weeks gestation for Stage 1 IUGR (decreased diastolic flow) 1
  • Earlier delivery may be indicated if there is progression to more advanced stages or evidence of fetal compromise

Antenatal Interventions

  • Maternal disease treatment if applicable
  • Optimization of maternal nutrition
  • Consideration of bed rest to improve uteroplacental perfusion

Progression of IUGR Stages

IUGR can progress through stages as placental function deteriorates:

  • Stage 1 (Decreased diastolic flow): Deliver >37 weeks
  • Stage 2 (Absent end-diastolic flow): Deliver >34 weeks
  • Stage 3 (Reversed end-diastolic flow): Deliver >32 weeks 1

Importance of Doppler Assessment

Umbilical artery Doppler assessment is crucial in IUGR management as it:

  • Significantly decreases the likelihood of labor induction
  • Reduces cesarean delivery rates
  • Decreases perinatal mortality (1.2% vs 1.7%; relative risk, 0.71) 1

Common Pitfalls in IUGR Management

  • Failure to distinguish between constitutional small-for-gestational-age (SGA) and pathological IUGR
  • Inadequate surveillance leading to missed opportunities for intervention
  • Delayed delivery when Doppler studies indicate significant placental insufficiency
  • Failure to administer antenatal corticosteroids when delivery is anticipated before 34 weeks

Antepartum surveillance with umbilical artery Doppler should be initiated when the fetus is viable and IUGR is suspected, as its use is associated with a significant decrease in perinatal mortality. 1

References

1
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

Do I need to refer a patient with a history of Intrauterine Growth Restriction (IUGR) to Maternal-Fetal Medicine (MFM)?
What are the American College of Obstetricians and Gynecologists (ACOG) guidelines for managing Intrauterine Growth Restriction (IUGR)?
What is the definition of Restrictive Intrauterine Growth (RCIU) and Small for Gestational Age (SGA)?
What is a reasonable screening tool for a baby with intrauterine growth restriction (IUGR)?
What is the cut off for diagnosing Intrauterine Growth Restriction (IUGR) in an anomaly scan?
What is the maximum recommended dose of Buspar (buspirone) per day?
What are the management options for sleep walking associated with Luvox (fluvoxamine)?
What are the recommended antibiotics for outpatient treatment of community-acquired pneumonia?
What is the safe creatinine clearance level for administering intravenous (IV) contrast for a computed tomography (CT) neck scan in patients with impaired renal function (kidney disease)?
How to manage anomia (difficulty naming objects) in normal aging?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question